Post-Viral Recovery: A Nutrition and Natural-Health Reference
1. Definition and Overview
"Post-viral syndrome" (PVS) is a catch-all name for long-lasting conditions or symptoms that can start after a viral infection. Other names include post-viral pain syndrome (PVPS) or post-viral fatigue syndrome (PVFS). Post-viral syndrome is a complex condition characterized by persistent pain, fatigue, musculoskeletal pain, neuropathic pain, neurocognitive difficulties, and sleep disturbances that can occur after an individual has recovered from a viral infection.
These symptoms can affect multiple systems, including the nervous, muscular, and immune systems, and can persist for months or years after the initial illness has resolved. In some patients, these syndromes evolve into or overlap with conditions like Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID, or autonomic dysfunction disorders such as POTS (Postural Orthostatic Tachycardia Syndrome).
Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia and joint pain, cognitive impairments, unrefreshing sleep, autonomic dysfunction, and neuropsychiatric symptoms. It includes myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS); fibromyalgia (FM); and more recently post-COVID-19 condition (long COVID). To date, there are no definitive clinical case criteria and no FDA-approved pharmacological therapies for PVFS.
The current PASC definition in the NIH RECOVER (REsearching COVID to Enhance Recovery) Initiative program is: "ongoing, relapsing, or new symptoms, or other health effects occurring after the acute phase of SARS-CoV-2 infection (i.e., present four or more weeks after the acute infection)." While this definition specifically addresses SARS-CoV-2, it reflects the broader framework applied to post-viral recovery contexts generally.
Between 10% and 35% of people with PVS will meet the criteria for chronic fatigue syndrome after six months.
2. Clinical Presentation: Symptoms and Affected Systems
This multifactorial condition displays over 200 symptoms and affects multiple tissues, organs, and biological systems (i.e., ears, eyes, head, nose, throat, kidney, brain, cardiopulmonary, endocrine, gastrointestinal (GI), musculoskeletal, neuropsychiatric, and systemic) to varying degrees.
2.1 Respiratory System
Post-COVID respiratory manifestations comprise coughing and shortness of breath. Furthermore, arrhythmias, palpitations, hypotension, increased heart rate, venous thromboembolic diseases, myocarditis and acute heart failure are usual cardiovascular events. 20.70% of reports on long-term COVID-19 symptoms were on abnormal lung functions.
2.2 Nervous System and Cognitive Function
Among neurological manifestations, headache, peripheral neuropathy symptoms, memory issues, lack of concentration and sleep disorders are most commonly observed with varying frequencies. 24.13% of long-term symptom reports were on neurologic complaints and olfactory dysfunctions.
Research is mapping brain and nervous system abnormalities post-infection, such as dysregulation of the glymphatic system (the waste removal system for cerebrospinal fluid) or nervous system issues, which may explain symptoms like brain fog and dizziness upon standing.
2.3 Musculoskeletal System
The pain can be either musculoskeletal in origin (e.g., myalgia, arthralgia) or neuropathic (e.g., myelitis, allodynia, postherpetic neuralgia). In some cases, pain begins during the acute phase of the viral infection and continues into the postinfectious phase. There are other cases in which new-onset pain develops weeks to months after recovery from infection.
2.4 Fatigue and Post-Exertional Malaise
Fatigue is the most common symptom of post-viral syndrome; over 90% of polio survivors have reported new-onset or increased fatigue, and 41% reported that fatigue interfered with their ability to be productive at work. More recently, COVID-19 has also been found to be associated with post-viral fatigue because a significant minority of patients have experienced continued fatigue and anhedonia after surviving the disease.
Post-exertional malaise (PEM) is a worsening of symptoms following physical, cognitive, or emotional activity that typically intensifies 12–48 hours after an activity and lasts for days or even weeks, and is considered one of the most disabling features of post-viral recovery.
2.5 Gastrointestinal and Metabolic Systems
PASC is highly heterogenous and may be associated with multisystem tissue damage/dysfunction including acute encephalitis, cardiopulmonary syndromes, fibrosis, hepatobiliary damages, gastrointestinal dysregulation, myocardial infarction, neuromuscular syndromes, neuropsychiatric disorders, pulmonary damage, renal failure, stroke, and vascular endothelial dysregulation.
2.6 Psychiatric and Neuropsychiatric Symptoms
Main symptoms identified by a majority of studies were fatigue (25% to 85%) and sleep problems (20% to 79%). Long COVID is a chronic, multi-system condition that heterogeneously affects multiple parts of the body associated with systemic inflammation, brain fog, depression, joint pain, and loss of appetite.
3. Underlying Pathophysiological Mechanisms
Immune dysregulation, autoimmunity, dysautonomia, endothelial dysfunction (ED), occult viral persistence, reactivation of pre-existing chronic viral infections as well as coagulopathies are some of the main underlying pathophysiological mechanisms described.
3.1 Viral Persistence and Immune Dysregulation
Proposed mechanisms include persistence of virus in the body causing autoimmunity, immune dysfunction, and autonomic dysregulation. Long COVID appears to be accompanied by an auto-immune multi-faceted syndrome where the virus or viral antigen persistence causes continuous stimulation of the immune response, resulting in multi-organ immune dysregulation.
The discussed contributors to PASC symptoms include sequelae from acute SARS-CoV-2 injury to one or more organs, persistent reservoirs of the replicating virus or its remnants in several tissues, re-activation of latent pathogens such as Epstein–Barr and herpes viruses in COVID-19 immune-dysregulated individuals.
3.2 Mitochondrial Dysfunction and Oxidative Stress
Persistent virally induced dysregulation of mitochondrial bioenergetics leads to imbalances in redox states and excessive production of reactive oxygen species, which fuels a cascade of cellular events that precipitate chronic symptoms such as fatigue, exercise intolerance, brain fog, and autonomic dysfunction.
Mitochondria, the cellular organelles responsible for tissue energy production, have recently garnered attention in research into PVFS due to their crucial role in cellular bioenergetic metabolism in these conditions.
3.3 Gut-Brain Axis Dysregulation and Dysbiosis
Evidence suggests that Long COVID patients often have abdominal discomfort and dysbiosis. Gut dysbiosis can cause changes in blood metabolites such as amino acids, fatty acids, and bile acids, which may contribute to systemic inflammation in Long COVID patients.
Gut-brain axis dysregulation accompanied by decreased production of short-chain fatty acids, impaired enteroendocrine cell function, and increased leakiness of the gut favors translocation of pathogens or lipopolysaccharide in circulation causing the release of pro-inflammatory cytokines. The altered Hypothalamic-Pituitary-Adrenal axis is accompanied by the reduced level of neurotransmitter, and decreased stimulation of the vagus nerve, which may cause neuroinflammation and dysregulation of serum cortisol levels.
ME/CFS and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis.
3.4 Autonomic and Neuroendocrine Disruption
ME/CFS is a serious, complex, and chronic multisystem illness of unknown etiology, often triggered by a persistent viral infection (for this reason, it is also known as post-viral fatigue syndrome). It is characterized by unexplained and persistent post-exertional fatigue, which is unrelieved by rest and made worse by physical and mental effort, along with other core symptoms such as the disruption of cognitive, immunometabolic, autonomic, and neuroendocrine pathways.
3.5 Inflammation and Cytokine Dysregulation
Micro-ischemic disease, neuropathy, autoimmune processes, mast-cell activation, and impaired blood-brain barriers have all been implicated in the pathological processes of this syndrome with varying degrees of supportive evidence.
4. Contributing and Associated Factors
- Severity of acute illness: Post-acute infectious syndromes can manifest in several ways from tissue damage to the onset of autoimmunity, dysregulation of the microbiota–gut–brain axis and symptoms resulting from the chronic stimulation of the immune system.
- Age and sex: The incidence rate ratio for WHO post-COVID condition was highest in the middle age groups between 40 and 69 years.
- Immune status: Post-viral syndrome may be more prevalent or apparent in people with weakened immune systems.
- Micronutrient status: Micronutrients such as vitamin D and zinc play a key role in the body's response against oxidation and infection, and deficiencies may predispose individuals to more severe or prolonged post-viral illness.
- Gut health and microbiome composition: Gut dysbiosis, resulting from an imbalance in the gut microbiome, can induce excessive production of reactive oxygen species, leading to inflammation, DNA damage, and activation of the immune system. Gut dysbiosis-induced inflammation can also disrupt the gut barrier integrity and increase intestinal permeability, which allows gut-derived toxic products to enter the liver and systemic circulation, further triggering oxidative stress.
- Pre-existing chronic conditions: Physiological changes that underlie post-COVID conditions share similarities with ME/CFS. The shared pathophysiological mechanisms might include dysregulated energy metabolism, exercise-induced plasma metabolome alterations, dysbiosis, and immune cell dysfunction.
5. Nutrients Studied in Relation to Post-Viral Recovery
5.1 Vitamin D
Scientific Evidence
In one study, 681 post-COVID outpatient participants with long-COVID-19 were re-evaluated 6 months after hospital discharge. Vitamin D deficiency was detected in 35.6% of participants, and therefore vitamin D was an independent risk factor for long-COVID-19.
Low vitamin D was observed in 26% of post-COVID clinic patients, most commonly in male participants (odds ratio = 1.77, 95% confidence interval 1.12–2.79). The authors reported that patients with vitamin D deficiency performed worse on the 6-minute walking test, particularly in those older than 65 years.
Of 97 patients with long COVID during the Omicron phase, sixty-six patients (68%) were classified in a vitamin D deficient group. The median serum concentrations of 25-OHD were 14.8 ng/mL in the vitamin D deficient group and 22.9 ng/mL in the non-deficient group.
A pilot clinical trial aimed at analyzing the effect of vitamin D supplementation on muscle fitness in 30 elderly patients during the recovery phase after SARS-CoV-2 infection reported that treatment with cholecalciferol (2000 IU/day) vs placebo carried out for 6 weeks was associated with a reduction of serum creatine kinase levels and with slight nonsignificant improvements in physical tests.
In one study, 28 patients diagnosed with ME/CFS after COVID-19 vaccination who had deficient or insufficient serum 25(OH) vitamin D levels were instructed to increase sun exposure and consume vitamin D-rich foods (including supplements). As a result, 23 of 28 patients (82.1%) no longer met the diagnostic criteria for ME/CFS. This prior study was a retrospective case series report, and a prospective randomized controlled clinical trial was needed to establish the efficacy of vitamin D replacement therapy guidance for ME/CFS following COVID-19 vaccination.
No randomized controlled trial has been published to date that has found that vitamin D affects long COVID-19 syndrome. Evidence remains observational or from small trials; the association is consistent but causal proof is still lacking.
Vitamin D, interacting with its receptor, triggers the regulation of several genes involved in the immune system and enhances the innate and adaptive immune response against respiratory infections.
5.2 Zinc
Scientific Evidence
Zinc was shown to be potentially effective in both the treatment and prevention of COVID-19 and viral respiratory infections, although existing data are limited and incomplete.
Key dietary components such as vitamins C, D, E, zinc, selenium and the omega-3 fatty acids have well-established immunomodulatory effects, with benefits in infectious disease. Evidence for zinc's specific role in post-viral recovery (as distinct from acute infection) is limited; most human trial data address acute-phase viral illness rather than the post-recovery period.
5.3 Vitamin C (Ascorbic Acid)
Scientific Evidence
Research indicates that Vitamin C may have a mitigating effect on viral respiratory infections. Much of the literature focuses on the breadth of possible or potential nutrition-based measures, including dietary protein, omega-3 fatty acids, vitamin A, vitamin D, vitamin E, vitamin B1, vitamin B6, vitamin B12, vitamin C, iron, zinc, and selenium. Evidence for Vitamin C in the post-viral phase specifically is preliminary and largely extrapolated from acute-infection and general immune studies; dedicated post-viral recovery RCTs are sparse.
5.4 Omega-3 Fatty Acids
Scientific Evidence
A feasibility pilot clinical trial was initiated to determine the feasibility of a clinical trial for omega-3 supplementation versus placebo in healthcare workers for post-COVID recovery. It was intended to serve as a proof-of-concept for a future, grant-funded study to evaluate the efficacy of omega-3 supplementation among a larger population recovering from COVID-19, and to determine which symptoms of long COVID syndrome (if any) are most affected by taking an omega-3 supplement. This trial signals that human evidence for omega-3 supplementation specifically in post-viral recovery remains early-stage and preliminary.
Key dietary components such as vitamins C, D, E, zinc, selenium and the omega-3 fatty acids have well-established immunomodulatory effects, with benefits in infectious disease. Understanding the roles of vitamins A, B, and E is hampered by limited data availability in the specific context of post-viral recovery.
5.5 Coenzyme Q10 (CoQ10)
Scientific Evidence
Coenzyme Q10 (CoQ10) is a popular nutritional supplement, an antioxidant and an essential component of the mitochondrial electron transport chain. Several clinical studies have suggested that fatigue can be reduced by antioxidant supplementation.
Randomised controlled clinical trials have reported significant symptomatic benefits in the treatment of these disorders, particularly for fibromyalgia; further randomised controlled trials are required to confirm the efficacy of CoQ10 supplementation in patients with ME/CFS and long COVID. No serious adverse effects have been reported from clinical studies supplementing CoQ10 in patients with PVFS, or in a wide range of other chronic disorders.
Other potential therapeutic agents for the treatment of PVFS have been suggested; these include generalised antioxidants which can restore mitochondrial function, such as N-acetylcysteine; glutathione and catalase; IL-6R and IL-1 receptor blockers, such as the antibody tocilizumab, to reduce levels of pro-inflammatory cytokines.
Evidence strength for CoQ10 in ME/CFS-type post-viral fatigue is preliminary: RCT data exist but trial sizes are small and heterogeneous; it has not been studied specifically in broader post-viral syndrome populations in large trials.
5.6 Selenium
Scientific Evidence
Selenium and magnesium emerge as potential preventive measures for both COVID-19 and viral respiratory infections, though evidence in the specific post-viral phase is limited. Exploring the potential synergistic effects of combining probiotics/synbiotics with other bioactives with immunomodulatory and anti-oxidative properties, such as CoQ10 and selenium or CoQ10 and lipoic acid, warrants further investigation.
5.7 Magnesium
Scientific Evidence
Magnesium plays a key role in energy metabolism, muscle function, and nervous system health. Deficiency can worsen post-viral fatigue and sleep disturbances. Dedicated RCT evidence for magnesium supplementation in post-viral syndromes is very limited; most data are from general fatigue or sleep research populations.
5.8 B Vitamins
Beneficial gut microbial metabolites including SCFAs, polyamines, and B vitamins suppress inflammation and support cellular homeostasis by maintaining mitochondrial function and antioxidant defense. B vitamins (particularly B12, B6, and folate) are implicated in post-viral neurological recovery through their roles in one-carbon metabolism and methylation, but human clinical trial data specific to post-viral recovery contexts are limited.
6. Bioactive Plant Compounds and Natural Ingredients
6.1 Quercetin
Traditional Use
Quercetin is a safe natural anti-oxidant and anti-inflammatory polyphenolic compound found in various natural sources including onion, red grapes, honey, and citrus fruits. It has been a constituent of traditional dietary patterns across multiple cultures for centuries through food consumption, though it was not historically isolated or named as such.
Scientific Evidence
Quercetin has been studied in various types and models of viral infection due to its promising antiviral effects in inhibiting polymerases, proteases, reverse transcriptase, suppressing DNA gyrase, and binding viral capsid proteins.
One open-label clinical trial in Pakistan evaluated the effects of quercetin on viral clearance and symptom resolution in outpatients with mild to moderate COVID-19. In the trial, 108 patients who were not vaccinated against COVID-19 were randomized to receive quercetin plus standard of care or standard of care alone. The quercetin group received 200 mg quercetin with sunflower lecithin three times a day during the first week of the study and 200 mg twice daily during the second week.
The results show that the incorporation of quercetin phytosome into standard care shortened the recovery time and severity of COVID-19. Quercetin is a phenolic flavonol compound with established antioxidant, anti-inflammatory, and immuno-stimulant properties.
Quercetin has the ability to chelate zinc ions and act as a zinc ionophore. Therefore, quercetin could have antiviral activity against many RNA viruses. Evidence is preliminary and based largely on small, often unblinded trials, in-vitro data, and combination-product studies; high-quality, adequately powered RCTs specifically addressing post-viral recovery are lacking.
6.2 Probiotics
Scientific Evidence
The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain–immune–gut axis, may help in the management of symptoms in both conditions.
While these implications are promising, further research is needed to fully understand the mechanisms through which microbial-derived preparations may improve the management of ME/CFS and long COVID. Overall evidence for probiotics in post-viral syndrome is mechanistically plausible but clinically preliminary; RCT data are small and heterogeneous.
6.3 Chinese Herbal Medicine (Traditional Preparations)
Traditional Use
The anti-COVID-19 efficacy of several traditional Chinese or herbal medicine patent prescriptions (TCMPPs or THMPPs) was determined within a period of research; however, they were applied or passed clinical trials in only a few cases. Chinese herbal medicine has a centuries-long documented history of use for post-febrile weakness and fatigue states within Traditional Chinese Medicine (TCM) frameworks.
Scientific Evidence
A systematic review published in 2024 assessed Chinese herbal medicine (CHM) as a potential effective intervention in relieving post-viral fatigue. Overall, nineteen studies with 1921 patients were included. Results of individual trial or meta-analysis showed that CHM was better than no treatment (MD = −0.80 scores, 95% CI −1.43 to −0.17 scores, P = 0.01, 60 participants, 1 trial), or placebo. The authors evaluated evidence quality using GRADE and the Cochrane risk-of-bias tool. Overall, trial quality was variable, and the evidence is considered low-to-moderate certainty.
6.4 N-Acetylcysteine (NAC)
Scientific Evidence
N-acetylcysteine (NAC) has been suggested as a potential therapeutic agent for the treatment of PVFS, classified as a generalised antioxidant which can restore mitochondrial function. Evidence in post-viral contexts is currently based on mechanistic rationale and small trials; dedicated large RCTs in PVFS/long COVID are not yet available.
7. Dietary Patterns and Nutritional Strategies
7.1 Mediterranean Diet and Anti-Inflammatory Eating Patterns
Mediterranean diet is a healthy eating custom that emphasizes fruits, vegetables, olive oil consumption, and limited meat eating. Previous studies have shown that daily adherence to the Mediterranean diet has a positive effect on cardiovascular diseases, diabetes, arthritis, cancer, and obstructive sleep apnea, and is also associated with a significant reduction of total mortality.
Overall findings highlight that following a Mediterranean-type diet leads to a pronounced reduction in the concentrations of the majority of the evaluated inflammatory biomarkers, including IL-6, IL-1β, CRP, IL-8, and TNF-α. This meta-analysis of RCTs provides the most direct evidence linking the dietary pattern to the kinds of inflammatory pathways disrupted in post-viral illness.
Low-level chronic inflammation and activation of the innate immune response are suggested mechanisms for increased risk of lifestyle-induced diseases. To lower inflammatory load, clinicians suggest refraining from eating a Westernized diet and shifting toward a balanced dietary pattern resembling the well-studied Mediterranean diet. These include plant-based foods such as fruits, vegetables, and legumes, which contain phytonutrients shown to have anti-inflammatory effects such as polyphenols and flavonoids.
The Mediterranean diet comprises a wide range of nutrients which, both individually and collectively, exert positive effects on immunity, in large part mediated by the gut microbiota.
7.2 Ultra-Processed Foods and Gut Dysbiosis
Certain food groups, additives or ultra-processed food products may disturb the equilibrium of the gut microbiota, leading to gut dysbiosis, which in turn may result in alterations to the gut barrier, activation of the immune system, or damage, such as breakdown, of the intestinal barrier, with leakage of toxins, bacteria or other substances into the circulation, with potential for damage to the brain. Limiting ultra-processed food intake is therefore mechanistically relevant to post-viral gut-immune recovery.
7.3 Nutrition and Immune Competence
Nutrition plays a key role in every stage of the immune response, and together with lifestyle factors, such as smoking, alcohol consumption, exercise, sleep and stress, determines the quality of immune function.
Poor diet leads to weakened immune defences, which is usually related to lowered immunity and increased susceptibility to illness. Healthy eating habits tend to improve immune system function and lead to a lower likelihood of infection and better recovery in those who have been infected.
8. Lifestyle Factors Discussed in Authoritative Sources
8.1 Physical Activity and Pacing
Recent systematic reviews have shown that physical rehabilitation interventions are feasible, safe, and beneficial in people with long COVID by improving various physical, clinical, and psychological relevant outcomes. In addition, long COVID-related symptoms such as exertional dyspnoea or fatigue have been shown to improve following exercise training interventions. However, a recent Cochrane review concluded that the available evidence has several methodological limitations that prevent the formulation of robust suggestions for exercise practice.
Pacing typically comprises regulating activity to avoid post-exertional malaise (PEM), the worsening of symptoms after an activity. The presence of post-exertional malaise (PEM) is a significant barrier to physical exercise training in people with long COVID. Pacing strategies—including heart rate monitoring to stay below the anaerobic threshold—are advocated in the post-viral ME/CFS and long-COVID literature as an alternative or precursor to graded activity.
Long COVID is associated with several symptoms, including severe fatigue, a lower exercise capacity, unrefreshing sleep, autonomic dysfunction, for example postural orthostatic tachycardia syndrome (POTS), and post-exertional malaise (PEM), which is the worsening of symptoms after physical or mental exertion above an unknown patient-dependent threshold.
8.2 Sleep
Gaining a better insight into HRV responses during sleep, daily life activities and the recovery after moderate-to-heavy exercise will provide more fundamental insights into the pathophysiology of PEM and long COVID, and also help patients with structuring daily activities and prevent overexertion. Poor or unrefreshing sleep is both a prominent symptom and a potential amplifying factor in post-viral recovery, given sleep's established role in immune regulation and tissue repair.
8.3 Stress and Psychoneuroimmunology
Viruses cause the immune system to respond and attack them. This response causes stress and inflammation in the body. The effects of this response often leave people feeling down, fatigued, and sometimes depressed. Lifestyle factors, such as smoking, alcohol consumption, exercise, sleep and stress, determine the quality of immune function. Chronic psychological stress prolongs neuroendocrine dysregulation and is mechanistically associated with impaired recovery trajectories in post-viral conditions, though specific RCT data remain limited.
8.4 WHO Rehabilitation Guidance
In January 2023, the World Health Organization (WHO) suggested that people with long COVID and significant impact on everyday functioning should be referred to rehabilitation services. There was also a recommendation that the presence of PEM will require interventions to be modified.
9. Evidence Summary and Limitations
The post-viral recovery field is hampered by heterogeneous definitions, small and uncontrolled trials, and a tendency to conflate findings from acute infection with findings from the post-acute phase. Key points regarding evidence quality include:
- Vitamin D: Consistent observational association with long COVID risk and severity; no RCT has yet demonstrated that supplementation reverses established long COVID. Evidence grade: preliminary-to-moderate (observational).
- Zinc: Immunomodulatory mechanisms well-established; direct post-viral recovery trial data are limited. Evidence grade: preliminary.
- CoQ10: RCT data show benefit for fatigue in fibromyalgia and ME/CFS; long COVID–specific RCTs are still needed. Evidence grade: preliminary-to-moderate for ME/CFS overlap, incomplete for long COVID specifically.
- Quercetin: In-vitro and small open-label clinical data are promising but insufficient for firm conclusions. Evidence grade: preliminary.
- Chinese herbal medicine: Systematic review of 19 RCTs (1921 participants) shows some benefit for post-viral fatigue; GRADE certainty is low-to-moderate due to methodological limitations.
- Mediterranean diet / anti-inflammatory dietary patterns: Meta-analyses of RCTs support reduction in systemic inflammatory biomarkers. Evidence for direct benefit in post-viral recovery is indirect but mechanistically strong.
- Probiotics: Mechanistically plausible; clinical trial evidence in post-viral specific settings is small and heterogeneous.
- Pacing strategies: Supported by expert guidance (WHO, 2023) and observational data; high-quality RCT evidence is still accumulating.
References
- Post-Viral Pain, Fatigue, and Sleep Disturbance Syndromes: Current Knowledge and Future Directions – PMC
- Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) – PMC / eLife
- Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems – PMC
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review – PMC
- Post-viral symptoms and conditions are more frequent in COVID-19 than influenza – PMC
- Post-Viral Syndrome (PVS)/Post-Viral Fatigue Syndrome (PVFS) – Cleveland Clinic
- Psychiatric, Neurophysical and Neurocognitive Sequelae of Post-Acute COVID-19 Syndrome: A Systematic Review – PMC
- Mitochondrial Reactive Oxygen Species: A Unifying Mechanism in Long COVID – PMC
- Chronic inflammation in post-acute sequelae of COVID-19 modulates gut microbiome – PMC
- The Therapeutic and Prophylactic Potential of Quercetin against COVID-19 – MDPI Antioxidants
- Dietary Supplements in the Time of COVID-19 – NIH Office of Dietary Supplements
- Effectiveness of nutritional supplements in preventing and treating COVID-19 and viral respiratory infections – ScienceDirect
- Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19 – PMC
- Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors – PMC
- Effect of Vitamin D in Long COVID Patients – PMC
- Vitamin D in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After COVID-19 or Vaccination: A Randomized Controlled Trial – PMC
- Clinical Characteristics of Vitamin D Deficiency Detected in Long COVID Patients During the Omicron Phase – PMC
- Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview – IJMS / MDPI
- Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue in ME/CFS: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial – PMC
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis – PubMed
- Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review – PMC
- Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids – PubMed
- Nutritional and Wellness Strategies for Neurological and Psychiatric Recovery From Post-COVID Syndrome – PMC
- A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in ME/CFS: Implications for Long COVID – MDPI Nutrients
- Effects of Dietary Patterns on Biomarkers of Inflammation: A Systematic Review and Meta-Analysis of RCTs – PMC
- Mediterranean Diet as a Tool to Combat Inflammation and Chronic Diseases – PMC
- The Role of an Anti-Inflammatory Diet in Conjunction to COVID-19 – PMC
- The impact of the Mediterranean diet on immune function in older adults – PMC
- Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exertional Malaise – PMC
- A Review Article on Exercise Intolerance in Long COVID – PMC
- Chinese herbal medicine for post-viral fatigue: A systematic review of randomized controlled trials – PMC / PLOS ONE
- Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease – PMC
- Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases – PMC
- The Functional Medicine Approach to COVID-19: Nutrition and Lifestyle Practices – PMC
Go back